Home | News | Events | Press | Contact  

About UseNewsletterMessage BoardsAction CenterAdvocateWalk to End Alzheimer’sShopDonate

Find your chapter:

search by state

In My Community

Weekly e-news

We will not share your information.

Drug study in Tri-Cities seeks participants
Text Size controlsNormal font sizeMedium font sizeLarge font size

Zain Research in Richland, WA, is seeking research participants. Zain is now conducting a 26-week, Phase 3 study for participants with Mild to Moderate Alzheimer’s disease currently or previously receiving an acetylcholinesterase (AChEl) inhibitor medication. If eligible, participants may receive compensation for time and travel, close medical monitoring, and an optional open label dosing for 6 additional months. For additional information, contact Zain Research at 509.420.5053.


Alzheimer's Association

Our vision is a world without Alzheimer's
Formed in 1980, the Alzheimer's Association is the world's leading voluntary health organization in Alzheimer's care, support and research.